Sanford J. Siegel, M.D., F.A.C.S.
- CEO, Chesapeake Urology
Sanford J. Siegel, M.D., was named President and Chief Executive Officer of CUA Opco, LLC in August 2016.
Prior to assuming that role, he served as President and Chief Executive Officer of Chesapeake Urology Associates, P.A., (Chesapeake Urology) since September 2006. CUA Opco is a management services organization, which was formed to focus on expanding Chesapeake Urology’s model as an independent medical practice to urology groups across the nation.
Dr. Siegel founded the original Chesapeake Urology Associates, P.A. in 1999 and was elected President and Chief Executive Officer in September 2006 when Baltimore’s three largest urology practices merged. In that role, Dr. Siegel built the company into one of the country’s most prominent urology practices and the largest in the Mid-Atlantic Region.
Dr. Siegel had been in private practice, primarily in the Baltimore area, since 1983. He earned his medical degree from the University of Maryland School of Medicine and completed his specialty training in urology at Temple University Hospital in Philadelphia. He is certified by the American Board of Urology and a Fellow of the American College of Surgeons.
In 2006, Dr. Siegel initiated the Chesapeake Urology Associates Scholarship Fund in conjunction with the Central Scholarship Bureau to provide scholarship assistance to full-time students pursuing degrees in medicine, nursing and ancillary health fields. He also established the Chesapeake Urology Associates/American Urological Association’s Urology Care Foundation Research Scholar program to fund prostate cancer research. In 2007, he led the formation of the ZERO Prostate Cancer Challenge® (ZPCC, formerly the Great Prostate Cancer Challenge) to raise funds for prostate cancer research and awareness and to provide prostate cancer screenings to those in need. The ZPCC is the only physician-led program of its kind in the country and has grown to 40 chapters supported by urology practices across the nation.
Dr. Siegel is a recognized leader in the Baltimore and Maryland communities. He was honored by the State of Maryland with a Governor’s Citations for outstanding commitment to the prevention, diagnoses and treatment of prostate cancer in the African American community, and by the Maryland General Assembly with an Official Citation in recognition of his tireless dedication to prostate cancer research and treatment, and an Official Citation for outstanding leadership and significant contributions in the field of medicine. The City of Baltimore also recognized Dr. Siegel for his outstanding leadership and significant contributions to the field of medicine, his dedication to improving the health of minorities, and for his commitment to the betterment of the community. The Baltimore Sun Media Group awarded Dr. Siegel with its Top Leadership award in 2015.
Dr. Siegel is a member of the American Urological Association’s Urology Care Foundation Board of Directors. He is a founding member of the Large Urology Group Practice Association (LUGPA), which was formed in 2008, and served as a member of its Board of Directors and chair of both the Government Affairs and Advocacy committees from 2008 through October 2014. Dr. Siegel previously served on the board of directors for ZERO – The End of Prostate Cancer and currently is a board member of the Park Heights Community Health Alliance (PHCHA).
- George Washington University, B.A.
- University of Maryland School of Medicine, M.D.
- Temple University Urology Residency Program